EyeGene Inc. (KOSDAQ:185490)

South Korea · Delayed Price · Currency is KRW

1,950.00

+127.00 (6.97%)

At close: Aug 11, 2026

EyeGene Financials Overview

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	4,021	3,567	3,356	3,125	5,293	3,242
Revenue Growth	10.16%	6.29%	7.37%	-40.96%	63.27%	-3.61%
Gross Profit	1,165	1,088	1,147	1,865	2,687	1,465
Operating Income	-10,970	-9,935	-13,254	-27,086	-24,089	-35,004
Net Income	-16,219	-15,706	-12,128	-21,106	-25,953	-34,569
Earnings Per Share	-506.41	-561.70	-449.00	-975.06	-1210.28	-2053.18
EPS Growth	-	-	-	-	-	-

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	41,688	45,497	32,547	55,368	66,455	85,357
Total Debt	524.25	560.24	2,441	2,151	2,397	3,943
Net Cash (Debt)	41,164	44,936	30,107	53,217	64,058	81,413
Net Cash Growth	38.04%	49.26%	-43.43%	-16.92%	-21.32%	434.64%
Net Cash Per Share	1285.27	1607.06	1114.59	2458.55	2987.22	4298.37

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	-8,465	-5,981	-12,171	-20,120	-18,568	-30,004
Capital Expenditures	-104.85	-102.69	-1,514	-1,385	-767.86	-2,378
Free Cash Flow	-8,570	-6,084	-13,685	-21,506	-19,336	-32,382
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	28.98%	30.50%	34.18%	59.69%	50.76%	45.19%
Operating Margin	-272.82%	-278.53%	-394.95%	-866.63%	-455.07%	-1079.66%
Pretax Margin	-488.57%	-534.85%	-384.30%	-717.68%	-522.48%	-1068.84%
Profit Margin	-403.36%	-440.34%	-361.41%	-675.30%	-490.29%	-1066.25%
FCF Margin	-213.13%	-170.57%	-407.82%	-688.10%	-365.27%	-998.79%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 12, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PS Ratio	20.96	21.08	20.62	29.31	20.41	126.13